 Q BioMed Inc announced it has engaged EVERSANA, the pioneer of next-generation commercial services to the global life sciences industry, to immediately support the commercialization of Strontium89. Strontium89 Strontium Chloride Sr-89 Injection, USP is the only US Food and Drug Administration-approved radiotherapy currently available in the US indicated for metastatic cancer bone palliation. 